Pettitt AR. The role of alemtuzumab in chronic lymphocytic leukaemia patients with p53 defects. Hematol Meeting Rep [Internet]. 2009 Jun. 17 [cited 2024 Nov. 23];1(5). Available from: https://www.pagepress.org/journals/hmr/article/view/638